Descriptor English: | Rosiglitazone | ||||||
Descriptor Spanish: |
Rosiglitazona
| ||||||
Descriptor Portuguese: | Rosiglitazona | ||||||
Descriptor French: | Rosiglitazone | ||||||
Entry term(s): |
5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate Avandia BRL 49653 BRL-49653 BRL49653 Rosiglitazone Maleate |
||||||
Tree number(s): |
D02.886.675.933.500 D03.383.129.708.933.500 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077154 | ||||||
Scope note: | A thiazolidinedione that functions as a selective agonist for PPAR GAMMA. It improves INSULIN SENSITIVITY in adipose tissue, skeletal muscle, and the liver of patients with TYPE 2 DIABETES MELLITUS. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Hypoglycemic Agents |
||||||
Registry Number: | 05V02F2KDG | ||||||
CAS Type 1 Name: | 2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)- | ||||||
Public MeSH Note: | 2019; ROSIGLITAZONE was indexed under THIAZOLIDINEDIONES 2004-2018, and under THIAZOLES 1994-2003 |
||||||
History Note: | 2019 (1994) |
||||||
Related: |
Pioglitazone
MeSH | ||||||
DeCS ID: | 57524 | ||||||
Unique ID: | D000077154 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/07/02 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Rosiglitazone
- Preferred
Rosiglitazone Maleate
- Narrower
5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate
- Narrower
Avandia
- Narrower
BRL 49653
- Narrower
Concept UI |
M0237199 |
Scope note | A thiazolidinedione that functions as a selective agonist for PPAR GAMMA. It improves INSULIN SENSITIVITY in adipose tissue, skeletal muscle, and the liver of patients with TYPE 2 DIABETES MELLITUS. |
Preferred term | Rosiglitazone |
Concept UI |
M0398223 |
Preferred term | Rosiglitazone Maleate |
Concept UI |
M000639464 |
Preferred term | 5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate |
Concept UI |
M0359368 |
Preferred term | Avandia |
Concept UI |
M0237200 |
Preferred term | BRL 49653 |
Entry term(s) |
BRL-49653 BRL49653 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey